Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 2
1989 1
1990 1
1991 2
1992 3
1993 1
1994 1
1995 6
1996 5
1997 6
1998 6
1999 7
2000 4
2001 8
2002 7
2003 5
2004 8
2005 11
2006 8
2007 5
2008 8
2009 9
2010 13
2011 17
2012 17
2013 13
2014 12
2015 12
2016 12
2017 18
2018 14
2019 22
2020 17
2021 11
2022 9
2023 6
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

264 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Grade 1 Oral Cavity Mucositis or Stomatitis by Clinical Examination Classification, CTCAE"
Page 1
Randomized Phase II Trial of Fulvestrant Plus Everolimus or Placebo in Postmenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Resistant to Aromatase Inhibitor Therapy: Results of PrE0102.
Kornblum N, Zhao F, Manola J, Klein P, Ramaswamy B, Brufsky A, Stella PJ, Burnette B, Telli M, Makower DF, Cheema P, Truica CI, Wolff AC, Soori GS, Haley B, Wassenaar TR, Goldstein LJ, Miller KD, Sparano JA. Kornblum N, et al. J Clin Oncol. 2018 Jun 1;36(16):1556-1563. doi: 10.1200/JCO.2017.76.9331. Epub 2018 Apr 17. J Clin Oncol. 2018. PMID: 29664714 Free PMC article. Clinical Trial.
Prophylactic corticosteroid mouth rinses were not used. Results The addition of everolimus to fulvestrant improved the median progression-free survival from 5.1 to 10.3 months (hazard ratio, 0.61 [95% CI, 0.40 to 0.92]; stratified log-rank P = .02), indicating that …
Prophylactic corticosteroid mouth rinses were not used. Results The addition of everolimus to fulvestrant improved the median progres …
Low-level laser therapy in treatment of chemoradiotherapy-induced mucositis in head and neck cancer: results of a randomised, triple blind, multicentre phase III trial.
Legouté F, Bensadoun RJ, Seegers V, Pointreau Y, Caron D, Lang P, Prévost A, Martin L, Schick U, Morvant B, Capitain O, Calais G, Jadaud E. Legouté F, et al. Radiat Oncol. 2019 May 22;14(1):83. doi: 10.1186/s13014-019-1292-2. Radiat Oncol. 2019. PMID: 31118057 Free PMC article. Clinical Trial.
BACKGROUND: Low-level laser therapy (LLLT) also called Photobiomodulation therapy (PBMT) could reduce oral mucositis (OM) incidence and severity in head and neck cancer patients treated by chemoradiotherapy, however randomised data about efficacy and safety are miss …
BACKGROUND: Low-level laser therapy (LLLT) also called Photobiomodulation therapy (PBMT) could reduce oral mucositis (OM) inci …
Oral epithelial dysplasia: Causes, quantification, prognosis, and management challenges.
Tilakaratne WM, Jayasooriya PR, Jayasuriya NS, De Silva RK. Tilakaratne WM, et al. Periodontol 2000. 2019 Jun;80(1):126-147. doi: 10.1111/prd.12259. Periodontol 2000. 2019. PMID: 31090138 Review.
It is a microscopic diagnosis of immense clinical importance. The initial reports of oral potentially malignant disorders with oral epithelial dysplasia transforming to oral cancer helped in understanding the nature of oral malignancies. Since t …
It is a microscopic diagnosis of immense clinical importance. The initial reports of oral potentially malignant disorders with …
Commensal oral microbiota impacts ulcerative oral mucositis clinical course in allogeneic stem cell transplant recipients.
Bruno JS, Heidrich V, Knebel FH, de Molla VC, Parahyba CJ, Miranda-Silva W, Asprino PF, Tucunduva L, Rocha V, Novis Y, Arrais-Rodrigues C, Camargo AA, Fregnani ER. Bruno JS, et al. Sci Rep. 2022 Oct 20;12(1):17527. doi: 10.1038/s41598-022-21775-3. Sci Rep. 2022. PMID: 36266464 Free PMC article.
Oral mucositis (OM) is a complex acute cytotoxicity of antineoplastic treatment that affects 40-85% of patients undergoing hematopoietic stem-cell transplantation. ...A total of 13 patients (43%) developed ulcerative OM. We observed that specific taxa were associate …
Oral mucositis (OM) is a complex acute cytotoxicity of antineoplastic treatment that affects 40-85% of patients undergoing hem …
Results of postoperative interstitial brachytherapy of resectable floor of mouth tumors.
Ferenczi Ö, Major T, Akiyama H, Fröhlich G, Oberna F, Révész M, Poósz M, Polgár C, Takácsi-Nagy Z. Ferenczi Ö, et al. Brachytherapy. 2021 Mar-Apr;20(2):376-382. doi: 10.1016/j.brachy.2020.10.008. Epub 2020 Nov 26. Brachytherapy. 2021. PMID: 33250304 Review.
The incidence of local Grade 1, 2, and 3 mucositis was 25%, 64%, and 11%, respectively. Grade 4 side effect, that is soft tissue necrosis occurred in four cases (9%). ...
The incidence of local Grade 1, 2, and 3 mucositis was 25%, 64%, and 11%, respectively. Grade 4 side effect, tha …
BMI-1 expression increases in oral leukoplakias and correlates with cell proliferation.
Klein IP, Meurer L, Danilevicz CK, Squarize CH, Martins MD, Carrard VC. Klein IP, et al. J Appl Oral Sci. 2020;28:e20190532. doi: 10.1590/1678-7757-2019-0532. Epub 2020 Apr 27. J Appl Oral Sci. 2020. PMID: 32348447 Free PMC article.
Paraffin-embedded tissue blocks of 28 specimens of Non-dys OL, 33 of Dys OL, 9 of normal oral mucosa (NOM), 17 of inflammatory hyperplasia (IH), and 19 of oral squamous cell carcinomas (OSCC) were stained for Ki-67 and BMI-1 using immunohistochemistry. ...Con …
Paraffin-embedded tissue blocks of 28 specimens of Non-dys OL, 33 of Dys OL, 9 of normal oral mucosa (NOM), 17 of inflammatory hyperp …
Prognostic markers of lymphoma development in primary Sjogren syndrome.
Retamozo S, Brito-Zerón P, Ramos-Casals M. Retamozo S, et al. Lupus. 2019 Jul;28(8):923-936. doi: 10.1177/0961203319857132. Epub 2019 Jun 19. Lupus. 2019. PMID: 31215845 Review.
Sjogren syndrome is a systemic autoimmune disease that principally affects women between the fourth and sixth decades of life who present with sicca symptomatology caused by dryness of the main mucosal surfaces. The clinical spectrum of Sjogren syndrome extends from …
Sjogren syndrome is a systemic autoimmune disease that principally affects women between the fourth and sixth decades of life who present wi …
Management of radiation-induced oral mucositis in head and neck cancer patients: a real-life survey among 25 Italian radiation oncology centers.
Bergamaschi L, Vincini MG, Zaffaroni M, Pepa M, Angelicone I, Astone A, Bergamini C, Buonopane S, Conte M, De Rosa N, Deantoni C, Dell'Oca I, Di Gennaro D, Di Muzio N, Osti MF, Federico M, Ferini G, Franzese C, Gatti M, Grillo A, Iorio V, Manzo R, Marmiroli L, Martin G, Mazzuca F, Molinaro MA, Muto M, Pacelli R, Pepe A, Perillo A, Russo D, Salerno F, Spadaro P, Viola A, Iorio GC, Muto P, Ricardi U, Alterio D. Bergamaschi L, et al. Support Care Cancer. 2023 Dec 19;32(1):38. doi: 10.1007/s00520-023-08185-5. Support Care Cancer. 2023. PMID: 38110572 Free PMC article. Review.
Median treatment time was 41 days, with a mean percentage of interruption due to toxicity of 14.5%. Eighty percent of responders provide written oral cavity hygiene recommendations. Regarding RIOM prevention, sodium bicarbonate mouthwashes, oral mucosa barrie …
Median treatment time was 41 days, with a mean percentage of interruption due to toxicity of 14.5%. Eighty percent of responders provide wri …
LAIR-1 overexpression and correlation with advanced pathological grade and immune suppressive status in oral squamous cell carcinoma.
Yang LL, Zhang MJ, Wu L, Mao L, Chen L, Yu GT, Deng WW, Zhang WF, Liu B, Sun WK, Sun ZJ. Yang LL, et al. Head Neck. 2019 Apr;41(4):1080-1086. doi: 10.1002/hed.25539. Epub 2018 Dec 14. Head Neck. 2019. PMID: 30549148
BACKGROUND: This study aims to investigate the characteristic role of inhibitory receptor leukocyte-associated immunoglobulin-like receptor 1 (LAIR-1) in oral squamous cell carcinoma (OSCC). METHODS: The expressions of LAIR-1 and other immune-related m …
BACKGROUND: This study aims to investigate the characteristic role of inhibitory receptor leukocyte-associated immunoglobulin-like receptor …
Epidemiology, patient adherence, and costs of oral mucositis in routine care in stem cell transplantation.
Berger K, Staudenmaier T, Cenzer I, Crispin A, Strobach D, Ostermann H. Berger K, et al. Support Care Cancer. 2020 Jul;28(7):3113-3123. doi: 10.1007/s00520-019-05107-2. Epub 2019 Nov 5. Support Care Cancer. 2020. PMID: 31691033
PURPOSE: Limited data about oral mucositis (OM) in stem cell transplant patients with underlying hematological disease is available in Germany. ...A positive history of smoking (1.77 vs 2.69, p = 0.036) was associated with a lower OM grade, patients wi …
PURPOSE: Limited data about oral mucositis (OM) in stem cell transplant patients with underlying hematological disease is avai …
264 results